19 August 2016 | [Attachment]Company Announcement Pro Medicus 2016 Full Year Results - Acrobat pdf 189k
Highlights:
After-tax profit $6.37 million - up 98%
Underlying after-tax profit up 212%
Revenue increased to $27.58 million - up 57%
Cash reserves $17.1 million - up 32%
Final dividend of 1.5c per share unfranked; total for year 3c per share
Rapidly expanding footprint in North American market
Leading health imaging company Pro Medicus Limited [ASX: PME] today announced a full-year after-tax profit of $6.37 million for the 12 months to 30 June 2016 - a 98% increase on the previous corresponding period. Revenue for the year grew by 57% to $27.58 million.
The company's cash reserves grew to $17.1 million an increase of 32%. The company remains debt-free.
Directors announced an unfranked final dividend of 1.5c per share, making a total dividend for the year of 3c per share.
During the period the company made announcements for contracts with a minimum value of A$60 million including:
Allegheny Health Network, USA - Sept 2015, A$11 million five-year contract.
German Government Hospital - Nov 2015, A$3 million five-year contract.
Mercy Health System - April 2016, A$21 million seven-year contract with the seventh largest Catholic health care system in the USA.
Franciscan Missionaries of Our Lady Health System - April 2016, A$7 million, seven-year contract with the largest health system in the US state of Louisiana.
Mayo Clinic, July 2016, A$18 million, six-year contract with Mayo Clinic, USA.
Key drivers of the company's profit increase for the year were the significant increase in the performance of the North American operations, supplemented by a capital sale in Europe and a modest increase in Australian sales. As the Group's costs are relatively fixed, this increase in sales had a significant impact on profitability.
Dr Sam Hupert, Pro Medicus Chief Executive Officer, said 'This has been a good year for us. Not only did we continue to rapidly expand our North American footprint, we also made significant progress with implementing those contracts we have previously won. As a result, we are starting to see good growth in transaction based revenue in North America and the positive impact it is having on our margins.'
'We also had our first significant enterprise Hospital sale in Europe late in the first half and our Australian operations held their own in a difficult market all of which contributed to our result.'
Pro Medicus Limited published this content on 19 August 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 19 August 2016 00:35:06 UTC.
Original documenthttp://www.promed.com.au/pro-medicus-limited-full-year-results-2/
Public permalinkhttp://www.publicnow.com/view/B3BE507DA3D309C86ADC977BA3BD7D919F7CF574
Pro Medicus Limited is an Australia-based healthcare informatics company. The Company provides a full range of medical imaging software and services to hospitals, imaging centers and health care groups in Australia, North America and Europe. Its products include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro and Visage Ease. Its Visage RIS is a radiology information systems (RIS) medical software for practicing of management, training, installation and professional services. Visage RIS capabilities include patient registration, billing, scheduling, typing, HL7 integration, financial reporting, digital dictation and voice recognition integration. Its Visage 7.0 is a healthcare imaging software that provides clinicians with visualization capability for rapidly viewing 2-D, 3-D and 4-D medical images and picture archive and communication system (PACS)/digital imaging software that is sold directly and to original equipment manufacturers (OEM), training, installation and others.
PRO MEDICUS LIMITED 
